Experimental Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 83.4 pp 469-480
© The Physiological Society 1998
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conlon, K
Right arrow Articles by Kidd, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conlon, K
Right arrow Articles by Kidd, C
Experimental Physiology, Vol 83, Issue 4, 469-480
Copyright © 1998 by The Physiological Society


Article

The role of nitric oxide in the control by the vagal nerves of the heart of the ferret

K Conlon, T Collins, and C Kidd

This study focuses on the potential role for nitric oxide on the actions of the parasympathetic innervation to the heart. Earlier, we showed that the nitric oxide synthase (NOS) inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) reduced the bradycardia induced by stimulation of vagal efferent motor fibres and that these effects are reversible through administration of the NOS substrate L-arginine. In the present study, we show that D-arginine does not reverse the effects of the inhibitors and confirm that they are reversed by L-arginine. Another NOS inhibitor, NG-nitro-L-arginine (L-NOARG), produced similar effects which were not reversed by L-arginine. In an examination of the effect of increasing NO availability with the NO donor sodium nitroprusside the vagally induced bradycardia was enhanced at all frequencies tested. In a separate series, the effects of NOS inhibitors and NO donors on the dromotropic actions of the vagus were examined. The NOS inhibitor L-NAME, reduced the increase in atrio-ventricular conduction delay normally induced by efferent vagal stimulation at all frequencies tested both in the 'paced' and 'unpaced' heart. Further, sodium nitroprusside enhanced this delay. Overall the study indicates that NO has an important facilitatory role on both the chronotropic and dromotropic actions of the vagus nerve on the heart and that NO may be a rate-limiting factor in the cardiac responses to vagal stimulation.


This article has been cited by other articles:


Home page
HypertensionHome page
H. Kamendi, O. Dergacheva, X. Wang, Z.-G. Huang, E. Bouairi, C. Gorini, and D. Mendelowitz
NO Differentially Regulates Neurotransmission to Premotor Cardiac Vagal Neurons in the Nucleus Ambiguus
Hypertension, December 1, 2006; 48(6): 1137 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Farias III, K. Jackson, M. Johnson, and J. L. Caffrey
Cardiac enkephalins attenuate vagal bradycardia: interactions with NOS-1-cGMP systems in canine sinoatrial node
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2001 - H2012.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda and T. Okamura
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Chowdhary, S. L. Nuttall, J. H. Coote, and J. N. Townend
L-Arginine Augments Cardiac Vagal Control in Healthy Human Subjects
Hypertension, January 1, 2002; 39(1): 51 - 56.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Chowdhary, J. C. Vaile, J. Fletcher, H. F. Ross, J. H. Coote, and J. N. Townend
Nitric Oxide and Cardiac Autonomic Control in Humans
Hypertension, August 1, 2000; 36(2): 264 - 269.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the The Physiological Society.